| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |